Literature DB >> 12105321

Normal-appearing brain tissue MTR histograms in clinically isolated syndromes suggestive of MS.

A Traboulsee1, J Dehmeshki, P A Brex, C M Dalton, D Chard, G J Barker, G T Plant, D H Miller.   

Abstract

Segmented normal-appearing brain tissue (NABT) was investigated in 40 patients with a recent onset and 13 patients with a remote onset of a clinically isolated syndrome (CIS) using magnetization transfer ratio (MTR) histograms. Abnormalities were present in patients with a high risk for MS (recent onset and T2-weighted lesions present) and in those with a low risk for relapse (recent onset without T2-weighted lesions). Similar mild NABT abnormality was present with CIS and no further disease activity 14 years later. NABT MTR abnormality in CIS may indicate susceptibility to demyelination but not to disease progression.

Entities:  

Mesh:

Year:  2002        PMID: 12105321     DOI: 10.1212/wnl.59.1.126

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

Review 1.  Management of secondary-progressive multiple sclerosis.

Authors:  Gavin Giovannoni
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  Early-stage multiple sclerosis : what are the treatment options?

Authors:  Per Soelberg Sorensen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Magnetic resonance study of the influence of tissue damage and cortical reorganization on PASAT performance at the earliest stage of multiple sclerosis.

Authors:  Bertrand Audoin; My Van Au Duong; Jean-Philippe Ranjeva; Danielle Ibarrola; Irina Malikova; Sylviane Confort-Gouny; Elisabeth Soulier; Patrick Viout; André Ali-Chérif; Jean Pelletier; Patrick J Cozzone
Journal:  Hum Brain Mapp       Date:  2005-03       Impact factor: 5.038

4.  Motor cortical reorganization is present after a single attack of multiple sclerosis devoid of cortico-spinal dysfunction.

Authors:  Audrey Rico; Wafaa Zaaraoui; Jerome Franques; Shahram Attarian; Françoise Reuter; Irina Malikova; Sylviane Confort-Gouny; Elisabeth Soulier; Jean Pouget; Patrick J Cozzone; Jean Pelletier; Jean-Philippe Ranjeva; Bertrand Audoin
Journal:  MAGMA       Date:  2010-12-17       Impact factor: 2.310

Review 5.  Pharmacological treatment of early multiple sclerosis.

Authors:  Olaf Stüve; Jeffrey L Bennett; Bernhard Hemmer; Heinz Wiendl; Michael K Racke; Amit Bar-Or; Wei Hu; Robert Zivadinov; Martin S Weber; Scott S Zamvil; Maria F Pacheco; Til Menge; Hans-Peter Hartung; Bernd C Kieseier; Elliot M Frohman
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  A brain magnetization transfer MRI study with a clinical follow up of about four years in patients with clinically isolated syndromes suggestive of multiple sclerosis.

Authors:  Antonio Gallo; Marco Rovaris; Beatrice Benedetti; Maria Pia Sormani; Roberto Riva; Angelo Ghezzi; Vittorio Martinelli; Andrea Falini; Giancarlo Comi; Massimo Filippi
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

7.  A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS.

Authors:  Marco Rovaris; Elda Judica; Antonia Ceccarelli; Angelo Ghezzi; Vittorio Martinelli; Giancarlo Comi; Massimo Filippi
Journal:  J Neurol       Date:  2008-06-13       Impact factor: 4.849

Review 8.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

9.  Quantitative T2' imaging in patients with clinically isolated syndrome.

Authors:  L Y Reitz; M Inglese; J Fiehler; J Finsterbusch; B Holst; C Heesen; R Martin; S Schippling
Journal:  Acta Neurol Scand       Date:  2012-01-03       Impact factor: 3.209

10.  A three-year, multi-parametric MRI study in patients at presentation with CIS.

Authors:  Maria A Rocca; Federica Agosta; Maria P Sormani; Kryshani Fernando; Mar Tintorè; Tijmen Korteweg; Paola Tortorella; David H Miller; Alan Thompson; Alex Rovira; Xavier Montalban; Chris Polman; Frederik Barkhof; Massimo Filippi
Journal:  J Neurol       Date:  2008-02-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.